Is subcutaneous insulin administration adequate for the management of hyperglycemic crisis in COVID-19?

There is a desperate need to explore different insulin administration strategies, particularly in coronavirus disease 2019 (COVID-19) patients with hyperglycemic crisis. Noteworthily, diabetes mellitus (DM) and poorly controlled blood glucose increase the risk of mortality and severity of COVID-19....

Descripción completa

Detalles Bibliográficos
Autores principales: Permana, Hikmat, Soetedjo, Nanny Natalia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of Diabetes India. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301814/
https://www.ncbi.nlm.nih.gov/pubmed/32599534
http://dx.doi.org/10.1016/j.dsx.2020.06.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301814/
https://www.ncbi.nlm.nih.gov/pubmed/32599534
http://dx.doi.org/10.1016/j.dsx.2020.06.032

Ejemplares similares